Summary
By means of the gel filtration technique, the effect of nine benzo-diazepine derivates on the binding of l-tryptophan to human serum albumin was investigated. Using equimolar tryptophan and benzodiazepine concentrations, all benzodiazepines with binding constants higher than 104 (M−1), displace l-tryptophan from its binding site to a high degree. The mechanism of the displacement was characterized as a competition for a common binding site. Some of the benzodiazepines displace l-tryptophan to a greater extent than salicylic acid. The benzodiazepines and tryptophan are the only substances known with a high degree of stereospecific binding to human serum albumin. This study shows that there is only one binding site on the human serum albumin molecule, which binds tryptophan and the benzodiazepines in a highly stereospecific manner. Therefore it is concluded that the benzodiazepines and l-tryptophan must have similarities in their molecular structure, so that both can bind to the common binding site in such specific manner. These considerations are discussed in regard to the known influence of benzodiazepine derivatives on the l-tryptophan metabolism in brain. A direct involvement of the reported displacement in the pharmacological actions of the drugs seems not to be relevant because of their small therapeutical plasma levels.
Similar content being viewed by others
References
Ariens, E. J., Beckett, A. H.: Drug-receptor relationships, as regards molecular configuration. Proc. Fourth Int. Congr. Pharmacol., Basel 1969
Baumann, P., Duruz, E., Heimann, H.: Determination of free and bound tryptophan by ultrafiltration. Clin. chim. Acta 51, 35–40 (1974)
Berlin, A., Siwers, B., Agurell, S., Hiort, A., Sjöqvist, F., Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther. 13, 733–744 (1972)
Bourgoin, S., Faivre-Baumann, A., Benda, P., Glowinski, J., Hamon, M.: Plasma tryptophan and 5-HT metabolism in the CNS of the neoborn rat J. Neurochem. 23, 319–327 (1974)
Chase, T. N., Katz, R. I., Kopin, I. J.: Effect of diazepam on fate of intracisternally injected serotonin-C14. Neuropharmacology 9, 103–108 (1970)
Curzon, G., Knott, P. J.: Effect on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Brit. J. Pharmacol. 50, 197–204 (1974a)
Curzon, G., Knott, P. J.: Fatty acids and the disposition of tryptophan. In: Aromatic amino acids in the brain. Amsterdam: Elsevier Publ. 1974b)
Franz, J. W., Jähnchen, E., Krieglstein, J.: Der Einfluß von Pharmaka auf das Bindungsvermögen einer Albuminlösung für Promazin und Chlorpromazin. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 264, 462–475 (1969)
Gessa, G. L., Tagliamonte, A.: Serum free tryptophan: control of brain concentrations of tryptophan and of synthesis of 5-hydroxytryptamine. In: Aromatic amino acids in the brain. Amsterdam: Elsevier Publ. 1974
Gottschalk, L. A., Biener, R., Dinove, E. C.: Effect of oral and intramuscular routes of administration on serum chlordiazepoxid levels and the prediction of these levels from predrug fasting serum glucose concentrations. Res. Comm. Chem. Path. Pharmacol. 8, 697–702 (1974)
Gottschalk, L. A., Noble, E. P., Stolzoff, G. E., Bates, D. E., Cable, C. G., Uliana, R. L., Birch, H., Fleming, E. W.: Relationship of chlordiazepoxid blood levels to psychological and biochemical responses. In: The benzodiazepines. New York: Raven Press 1973
Guerniot, F., Poitou, P., Bohoun, C.: Serotonin synthesis in the rat brain after acetylsalicylic acid. administration. J. Neurochem. 22, 191–192 (1974)
Keen, P. M.: The displacement of three anionic drugs from binding to bovine serum albumin by various anionic compounds. Brit. J. Pharmacol. 26, 704–712 (1966)
Krieglstein, J., Kuschinsky, G.: Quantitative Bestimmung der Eiweißbindung von Pharmaka durch Gelfiltration. Arzneimittel-Forsch. 18, 287–289 (1968)
Lippmann, W., Pugsley, T. A.: Effects of benzoctamine and chlordiazepoxid on turnover and uptake of 5-hydroxytroptamine in the brain. Brit. J. Pharmacol. 51, 571–575 (1974)
Martelli, E. A., Corsico, N.: On the mechanism of lipomobilizing effect of chlordiazepoxid. J. Pharm. Pharmacol. 21, 59–60 (1969)
McArthur, J. N., Dawkins, P. D.: The effect of sodium salicylate on the binding of l-tryptophan to serum proteins. J. Pharm. Pharmacol. 21, 744–750 (1969)
McMenamy, R. H., Oncley, J. L.: The specific binding of l-tryptophan to serum albumin. J. biol. Chem. 233, 1436–1447 (1958)
McMenamy, R. H.: Binding of indole analogues to human serum albumin. Effect of fatty acids. J. biol. Chem. 240, 4235–4243 (1965)
Müller, W. E., Wollert, U.: Characterization of the binding of benzodiazepines to human serum albumin. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 229–237 (1973)
Müller, W. E., Wollert, U.: Influence of pH on the benzodiazepine-human serum albumin complex. Circular dichroism studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 67–82 (1974a)
Müller, W. E., Wollert, U.: Binding of d- and l-oxazepam hemisuccinate to bovine serum albumin. Res. Comm. Chem. Path. Pharmacol. 9, 413–420 (1974b)
Müller, W. E., Wollert, U.: High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate. Molec. Pharmacol. 11, 52–60 (1975)
Pande, C. S., McMenamy, R. H.: Binding of indole compounds with modified albumins. Characterization of the indole binding site. Biochim. biophys. Acta (Amst.) 342, 60–68 (1974)
Scatchard, G.: The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660–672 (1949)
Sjöholm, I., Grahnén, A.: Circular dichroism studies on the binding of l-tryptophan to human serum albumin. FEBS Letters 22, 109–112 (1972)
Sjöholm, I., Sjödin, T.: Binding of drugs to human serum albumin. 1. Circular dichroism studies on the binding of some analgesics, sedatives, and antidepressive agents. Biochem. Pharmacol. 21, 3041–3052 (1972)
Smith, H. G., Lakatos, C.: Effects of acetylsalicylic acid on serum protein binding and metabolism of tryptophan in man. J. Pharm. Pharmacol. 23, 180–189 (1971)
Solomon, H. M., Schrogie, J. J., Williams, D.: The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 17, 143–151 (1968)
Stein, J., Wise, C. D., Berger, B. D.: Antianxiety action of benzodiazepines: Decrease in activity of serotonin neurons in the punishment system. In: The benzodiazepines. New York: Raven Press 1973
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S., Gessa, G.: Effect of psychotropic drugs on tryptophan concentration in the rat brain. J. Pharmacol. exp. Ther. 177, 475–480 (1971)
Wallevik, K.: Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. biol. Chem. 248, 2650–2655 (1973)
Wise, C. D., Berger, B. D., Stein, L.: Benzodiazepines: Anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177, 180–183 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, W.E., Wollert, U. Benzodiazepines: Specific competitors for the binding of l-tryptophan to human serum albumin. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 17–27 (1975). https://doi.org/10.1007/BF00501811
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501811